Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1.243
1.161 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
AbbVie Inc
ABBV
|
$264,46 |
+0,2%
|
$467,25 B |
|
|
|
Amgen Inc
AMGN
|
$385,72 |
+1,6%
|
$208,18 B |
|
|
|
Gilead Sciences, Inc
GILD
|
$150,83 |
0%
|
$187,27 B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$509,435 |
-1,3%
|
$129,30 B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$787,52 |
-0,2%
|
$82,56 B |
|
|
|
argenx SE
ARGX
|
€871,4 |
+0,4%
|
$62,53 B |
|
|
|
Moderna Inc
MRNA
|
$154,195 |
-2,5%
|
$61,18 B |
|
|
|
CSL Ltd
CSL
|
AU$175,59 |
-1,1%
|
$59,84 B |
|
|
|
Natera Inc
NTRA
|
$362,4 |
-1,1%
|
$51,90 B |
1.156 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita